These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 3687457)
1. [Effect of 3,4-dihydroxyacetophenone on TXA2 release from rabbit platelets]. Wang Z; An Y; Liu Z; Zhu GQ; Huang RS Yao Xue Xue Bao; 1987 May; 22(5):330-4. PubMed ID: 3687457 [No Abstract] [Full Text] [Related]
2. [Effect of 3,4-dihydroxyacetophenone on rabbit platelet function]. Wang Z; Gao HQ; An Y; Zhu GQ; Yang ZM Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):187-92. PubMed ID: 6095591 [No Abstract] [Full Text] [Related]
3. [Effect of 3,4-dihydroxyacetophenone on the generation of PGI2-like substances in the rat aorta]. Wang Z; Gao HG; Zhu GQ; An Y; Huang RS Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):37-40. PubMed ID: 2945382 [No Abstract] [Full Text] [Related]
4. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [TBL] [Abstract][Full Text] [Related]
5. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172 [TBL] [Abstract][Full Text] [Related]
6. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation. Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560 [No Abstract] [Full Text] [Related]
7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation. Heinroth I; Block HU; Mest HJ Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555 [TBL] [Abstract][Full Text] [Related]
8. Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets. Giannessi D; De Caterina R; Gazzetti P; Bernini W; Masini S; Zucchelli GC J Nucl Med Allied Sci; 1982; 26(1):25-33. PubMed ID: 7108634 [No Abstract] [Full Text] [Related]
9. [Effects of neferine on platelet aggregation in rabbits]. Yu J; Hu WS Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209 [TBL] [Abstract][Full Text] [Related]
11. Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat. Jeremy JY; Mikhailidis DP; Thompson CS; Barradas MA; Dandona P Diabetes Res; 1988 Aug; 8(4):177-81. PubMed ID: 3233878 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben). Menys VC; Davies JA Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403 [TBL] [Abstract][Full Text] [Related]
14. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)]. Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078 [TBL] [Abstract][Full Text] [Related]
15. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. Simpson RM; Prancan A; Izzi JM; Fiedel BA Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160 [TBL] [Abstract][Full Text] [Related]
16. [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats]. Wei XR; Hu L; Du J Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):89-91. PubMed ID: 10375769 [TBL] [Abstract][Full Text] [Related]
17. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism. Pilo R; Aharony D; Raz A Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741 [TBL] [Abstract][Full Text] [Related]
18. RCS from human platelets: is it only thromboxane? Smith EF; Rücker W; Schrör K Eur J Pharmacol; 1983 Nov; 95(1-2):121-4. PubMed ID: 6667711 [TBL] [Abstract][Full Text] [Related]
19. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity. Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034 [TBL] [Abstract][Full Text] [Related]
20. [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets]. Yu W; Xu L Yao Xue Xue Bao; 1998; 33(1):62-3. PubMed ID: 11938938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]